MICKEY TYRRELL: Open Payments
NPI 1710925680 · VINITA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,068 in 229 payments from 30 companies in 2025. Trend: 2023 $3,676 · 2024 $3,854 · 2025 $4,068
Food & beverage: $3,918Education: $150
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 31 | $590 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 38 | $456 |
| Alkermes, Inc. | 19 | $394 |
| Teva Pharmaceuticals USA, Inc. | 11 | $340 |
| AstraZeneca Pharmaceuticals LP | 10 | $336 |
| Lundbeck LLC | 17 | $289 |
| Novo Nordisk Inc | 16 | $267 |
| PFIZER INC. | 15 | $232 |
| E.R. Squibb & Sons, L.L.C. | 10 | $198 |
| Janssen Pharmaceuticals, Inc | 12 | $197 |
Products named: FANAPT, CAPLYTA, ARISTADA, REXULTI, FARXIGA, COBENFY, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across OK — which companies pay providers there.
